Clinical trials
Phase 2 Obesity trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2012 | 1 |
| 2015 | 3 |
| 2017 | 4 |
| 2018 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2 |
| Maastricht University Medical Center | 2 |
| Rijnstate Hospital | 2 |
| TNO | 2 |
| Alizyme | 1 |
| Boehringer Ingelheim | 1 |
| Eli Lilly and Company | 1 |
| Goethe University | 1 |
| MedImmune LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 19 |
| Overweight | 6 |
| Diabetes Mellitus, Type 2 | 5 |
| Nutrition Disorders | 3 |
| Body Weight | 2 |
| Hyperinsulinism | 2 |
| Hypertension | 2 |
| Metabolic Diseases | 2 |
| Nutritional and Metabolic Diseases | 2 |
| Attention Deficit Disorder with Hyperactivity | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.